228 related articles for article (PubMed ID: 2538330)
1. A human melanoma-derived cell line (IGR39) with a very high number of vasoactive-intestinal-peptide (VIP) receptors. 1. Molecular characterization of the binding site.
Luis J; Martin JM; el Battari A; Reynier M; Marvaldi J; Pichon J
Eur J Biochem; 1989 Mar; 180(2):429-33. PubMed ID: 2538330
[TBL] [Abstract][Full Text] [Related]
2. A human melanoma-derived cell line (IGR39) with a very high number of vasoactive-intestinal-peptide (VIP) receptors. 2. Effect of VIP on cAMP production and on cell-surface VIP-binding sites.
Martin JM; Luis J; Marvaldi J; Pichon J; Pic P
Eur J Biochem; 1989 Mar; 180(2):435-9. PubMed ID: 2538331
[TBL] [Abstract][Full Text] [Related]
3. Structural and functional analysis of the human vasoactive intestinal peptide receptor glycosylation. Alteration of receptor function by wheat germ agglutinin.
Chochola J; Fabre C; Bellan C; Luis J; Bourgerie S; Abadie B; Champion S; Marvaldi J; el Battari A
J Biol Chem; 1993 Feb; 268(4):2312-8. PubMed ID: 8381403
[TBL] [Abstract][Full Text] [Related]
4. Solubilization of the active vasoactive intestinal peptide receptor from human colonic adenocarcinoma cells.
el Battari A; Martin JM; Luis J; Pouzol O; Secchi J; Marvaldi J; Pichon J
J Biol Chem; 1988 Nov; 263(33):17685-9. PubMed ID: 2846575
[TBL] [Abstract][Full Text] [Related]
5. Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas.
Le Meuth V; Farjaudon N; Bawab W; Chastre E; Rosselin G; Guilloteau P; Gespach C
Am J Physiol; 1991 Feb; 260(2 Pt 1):G265-74. PubMed ID: 1847591
[TBL] [Abstract][Full Text] [Related]
6. Molecular identification and structural requirement of vasoactive intestinal peptide (VIP) receptors in the human colon adenocarcinoma cell line, HT-29.
Couvineau A; Rousset M; Laburthe M
Biochem J; 1985 Oct; 231(1):139-43. PubMed ID: 2998337
[TBL] [Abstract][Full Text] [Related]
7. Characterization of vasoactive intestinal peptide (VIP) receptors in mammalian lung.
Dickinson KE; Schachter M; Miles CM; Coy DH; Sever PS
Peptides; 1986; 7(5):791-800. PubMed ID: 3025822
[TBL] [Abstract][Full Text] [Related]
8. Characterization of receptors for vasoactive intestinal peptide solubilized from the lung.
Paul S; Said SI
J Biol Chem; 1987 Jan; 262(1):158-62. PubMed ID: 3025200
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a common VIP-PACAP receptor in human small intestinal epithelium.
Salomon R; Couvineau A; Rouyer-Fessard C; Voisin T; Lavallée D; Blais A; Darmoul D; Laburthe M
Am J Physiol; 1993 Feb; 264(2 Pt 1):E294-300. PubMed ID: 8383439
[TBL] [Abstract][Full Text] [Related]
10. Photoaffinity labelling of the vasoactive-intestinal-peptide-binding site on intact human colonic adenocarcinoma cell line HT29-D4. Synthesis and use of photosensitive vasoactive-intestinal-peptide derivatives.
Martin JM; Darbon H; Luis J; el Battari A; Marvaldi J; Pichon J
Biochem J; 1988 Mar; 250(3):679-85. PubMed ID: 2839143
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells.
Gespach C; Bawab W; de Cremoux P; Calvo F
Cancer Res; 1988 Sep; 48(18):5079-83. PubMed ID: 2842044
[TBL] [Abstract][Full Text] [Related]
12. Distribution of vasoactive intestinal polypeptide (VIP) binding in circular muscle and characterization of VIP binding in canine small intestinal mucosa.
Mao YK; Barnett W; Coy DH; Tougas G; Daniel EE
J Pharmacol Exp Ther; 1991 Sep; 258(3):986-91. PubMed ID: 1653848
[TBL] [Abstract][Full Text] [Related]
13. Molecular characteristics and peptide specificity of vasoactive intestinal peptide receptors from rat cerebral cortex.
Couvineau A; Gammeltoft S; Laburthe M
J Neurochem; 1986 Nov; 47(5):1469-75. PubMed ID: 3020175
[TBL] [Abstract][Full Text] [Related]
14. Modulation of the expression of the VIP receptor by serum factors on the human melanoma cell line IGR39.
Bellan C; Fabre C; Secchi J; Marvaldi J; Pichon J; Luis J
Exp Cell Res; 1992 May; 200(1):34-40. PubMed ID: 1314189
[TBL] [Abstract][Full Text] [Related]
15. Characterization of receptors for VIP on pancreatic acinar cell plasma membranes using covalent cross-linking.
McArthur KE; Wood CL; O'Dorisio MS; Zhou ZC; Gardner JD; Jensen RT
Am J Physiol; 1987 Mar; 252(3 Pt 1):G404-12. PubMed ID: 2435170
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous solubilization of high-affinity receptors for VIP and glucagon and of a low-affinity binding protein for VIP, shown to be identical to calmodulin.
Andersson M; Carlquist M; Maletti M; Marie JC
FEBS Lett; 1993 Feb; 318(1):35-40. PubMed ID: 8382169
[TBL] [Abstract][Full Text] [Related]
17. Vasoactive intestinal peptide receptor regulation of cAMP accumulation and glycogen hydrolysis in the human Ewing's sarcoma cell line WE-68.
Van Valen F; Jürgens H; Winkelmann W; Keck E
Cell Signal; 1989; 1(5):435-46. PubMed ID: 2561912
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the immunomodulatory properties of the secretin-glucagon family of peptides on mouse lymphoid cell functions and the demonstration of specific receptors on T cells.
Nguyen TT; Krco CJ; Gores A; Go VL
Immunol Invest; 1987 Nov; 16(7):555-77. PubMed ID: 2832322
[TBL] [Abstract][Full Text] [Related]
19. Characterization and solubilization of vasoactive intestinal peptide receptors from rat lung membranes.
Provow S; Veliçelebi G
Endocrinology; 1987 Jun; 120(6):2442-52. PubMed ID: 3032591
[TBL] [Abstract][Full Text] [Related]
20. Modifications of the binding properties of the human VIP receptor of IGR39 cells by sulfhydryl reagents.
Fouchier F; Forget P; Pic P; Marvaldi J; Pichon J
Eur J Cell Biol; 1992 Dec; 59(2):382-8. PubMed ID: 1337321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
